RxDoctor Payments Data

Paul Saphier, MD

Neurological Surgery · Morristown, NJNPI 1154516532

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (47.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Penumbra, Inc. accounts for 70.6% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $3,379 and has fallen 91.9% since, to $275 in 2025.

$8,170in general payments, 2019–2025

Across 43 payments — averaging $190.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$6K
  • Balt USA, LLC$804
  • Qapel Medical Inc$703
  • Stryker$416
  • Siemens Medical Solutions USA, Inc.$145
  • Medtronic$115
  • plus $221 from 5 others
$153,342in research payments, 2019–2025

Across 79 payments — averaging $1941.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Penumbra, Inc.$153K

What the payments were for

  • Speaking & faculty fees$3,90048%
  • Travel & lodging$5377%
  • Food & beverage$3,73346%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,170 in reported general payments places this provider in the 65th percentile of 174 neurological surgery providers in New Jersey.

See all neurological surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$74,714
Medicare patients
168
Services billed
384

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate28$361

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Morristown

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →